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OBJECTIVE — Inthisstudy,wesoughttodeterminewhetherpostprandialinsulinsecretion,
insulin action, glucose effectiveness, and glucose turnover were abnormal in type 2 diabetes.
RESEARCH DESIGN AND METHODS — Fourteen subjects with type 2 diabetes and
11 nondiabetic subjects matched for age, weight, and BMI underwent a mixed-meal test using
thetriple-tracertechnique.Indexesofinsulinsecretion,insulinaction,andglucoseeffectiveness
were assessed using the oral “minimal” and C-peptide models.
RESULTS — Fastingandpostprandialglucoseconcentrationswerehigherinthediabeticthan
nondiabetic subjects. Although peak insulin secretion was delayed (P  0.001) and lower (P 
0.05)intype2diabetes,theintegratedtotalpostprandialinsulinresponsedidnotdifferbetween
groups. Insulin action, insulin secretion, disposition indexes, and glucose effectiveness all were
lower (P  0.05) in diabetic than in nondiabetic subjects. Whereas the rate of meal glucose
appearance did not differ between groups, the percent suppression of endogenous glucose
production (EGP) was slightly delayed and the increment in glucose disappearance was sub-
stantiallylower(P0.01)indiabeticsubjectsduringtheﬁrst3haftermealingestion.Together,
these defects resulted in an excessive rise in postprandial glucose concentrations in the diabetic
subjects.
CONCLUSIONS — When measured using methods that avoid non–steady-state error, the
rate of appearance of ingested glucose was normal and suppression of EGP was only minimally
impaired.However,whenconsideredinlightoftheprevailingglucoseconcentration,bothwere
abnormal. In contrast, rates of postprandial glucose disappearance were substantially decreased
due to defects in insulin secretion, insulin action, and glucose effectiveness.
Diabetes Care 32:866–872, 2009
G
lucose concentrations are deter-
mined by the balance between the
rate of glucose entering and leav-
ing the systemic circulation. Fasting hy-
perglycemia in type 2 diabetes occurs
when endogenous glucose production
(EGP) is inappropriately increased and
glucose disappearance (Rd) inappropri-
ately decreased when considered in
light of prevailing glucose and insulin
concentrations (1–4). The cause of the
excessive rise in glucose that occurs af-
ter mixed-meal ingestion is not well
established. Whereas postprandial sup-
pression of EGP has consistently been re-
ported to be delayed (5–7), rates of
appearance of glucose in the meal (MRa)
have been reported to be increased, de-
creased, or not different from those ob-
served in nondiabetic subjects (5,6,8).
Similarly, postprandial Rd has been re-
ported to be increased or not different
compared with that observed in nondia-
betic subjects (5–10).
However,alloftheabovestudieshave
used a dual-tracer approach in which one
tracer is added to ingested glucose and
another is infused intravenously. The in-
travenously infused tracer is used to trace
the rate of appearance of both ingested
tracerandrateoftotalglucoseappearance
(Ra). MRa is calculated by multiplying the
rateofappearanceofingestedtracerbyits
enrichment in the meal, and EGP is cal-
culated by subtracting MRa from Ra. Rd is
calculated by subtracting the change in
plasma glucose mass from Ra. Unfortu-
nately, the validity of all of these calcula-
tionsisjeopardizedbythemarkedchange
in tracer-to-tracee ratios that occurs after
carbohydrate ingestion with the dual-
tracer approach (11,12). Perhaps even
moreproblematic,differencesinMRaand
Ra can lead to differences in tracer-to-
traceeratios(12).Dependingonthemag-
nitudeofchangeinglucoseconcentration
and turnover, non–steady-state error
could account for the discrepant results
among previous studies that have used
the dual-tracer method to compare the
pattern of postprandial glucose metabo-
lism in diabetic and nondiabetic subjects
(5–10).
The present studies were undertaken
to reassess the relative contribution of al-
terations in EGP, MRa, and Rd to post-
prandial hyperglycemia in individuals
with diabetes using a triple (rather than
dual)-tracer approach (11) that is de-
signed to minimize postprandial changes
in tracer-to-tracee ratios that are used to
measure MRa and EGP. We also used the
oral “minimal” and C-peptide models
(13,14) to determine whether changes in
pattern of postprandial glucose metabo-
lismareaccompaniedbyalterationsinin-




Mayo Clinic Institutional Review Board,
14 diabetic and 11 nondiabetic subjects
provided written informed consent to
participate in the study. Subject charac-
teristics are provided in supplementary
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All participants were in good health,
and none were regularly engaged in vig-
orous physical exercise. Oral antihyper-
glycemic medications were discontinued
3 weeks before the study. Two diabetic
subjects and one nondiabetic subject
were receiving thyroxine replacement
therapy but had normal thyroid-
stimulating hormone levels. All partici-
pants were instructed to follow a weight
maintenance diet for 3 days before the
study. At screening, body composition
and visceral fat were measured using
dual-energyX-rayabsorptiometryanda
single-cut computed tomographic scan
(15).
Subjects were admitted to the Mayo




ing by mouth except water until the fol-
lowing morning. At 0600 h on the
morning of the study, an 18-G cannula
was inserted in a hand vein, and the hand
was placed in a heated Plexiglas box
(55°C) to obtain arterialized venous
blood samples. Another 18-G cannula
wasinsertedintotheoppositeforearmfor
tracer infusion. A primed-continuous in-
fusion of [6,6-
2H2]glucose (14.8 mg/kg
prime and 0.148 mg/kg continuous;
MassTrace, Woburn, MA) was started at
0700 h (time 120) and continued until
the end of the study. For diabetic individ-
uals, the prime dose was adjusted up-
ward, depending on the ambient glucose
concentration.At0900h(time0)amixed
meal (10 kcal/kg; 45% carbohydrate,
40% fat, and 15% protein) consisting of




consumed within 15 min. An infusion of
[6-
3H]glucose also was started at time 0,
and the rate was varied to mimic the an-
ticipatedrateofappearanceof[1-
13C]glu-
cose contained within the meal (11,14).
Simultaneously, the [6,6-
2H2]glucose in-
fusion rate was altered to mimic the an-
ticipated fall in the rate of EGP.
Analytical techniques
Arterialized samples were placed on ice,
centrifuged at 4°C, separated, and stored
at 20°C until assay. The plasma glucose
concentration was measured using a glu-
cose oxidase method (YSI, Yellow
Springs, OH). The plasma insulin con-
centration was measured using a chemi-
luminescence assay (Access Assay;
Beckman Coulter, Chaska, MN), and C-
peptide was measured using a radioim-




counting as previously described (11).
Plasma enrichment of [1-
13C]glucose and
[6,6-
2H2]glucose was measured using gas
chromatography–mass spectrometry
(Thermoquest, San Jose, CA) to simulta-
neously monitor the C1,2 and C3–6 frag-
ments (16).
Calculations
Fasting and postprandial rates of glucose
turnover were calculated as detailed else-
where (11). Brieﬂy, the systemically in-
fused [6-
3H]glucose was used to trace the
systemicrateofappearanceof[1-
13C]glu-
cose that was contained in the meal,
whereas [6,6-
2H2]glucose was used to
trace the rate of appearance of endog-
enously produced glucose. The ratio of
the plasma concentration of [6-
3H]glu-
cose to the plasma concentration of
[1-
13C]glucose was used to calculate the
rateofappearanceofingested[1-
13C]glu-
cose, and the ratio of plasma concentra-
tion of [6,6-
2H2]glucose to the plasma
concentration of endogenously produced
glucose was used to calculate EGP. The
plasma concentration of endogenously
produced glucose was calculated by sub-
tracting the concentration of exogenously
derived (ingested) glucose (i.e., plasma
[1-
13C]glucose concentration times meal
[1-
13C]glucose enrichment) from the to-
tal plasma glucose concentration (11).
Indexes of net insulin action (Si), glu-
cose effectiveness (Sg), and the ability of
insulin (Si*) and glucose (Sg*) to stimu-
late glucose disposal were calculated us-
ing the oral minimal model as described
previously (13,14,17). Indexes of insulin
secretion including the total response to
the glycemic stimuli (total), the response
to a change in glucose concentration
(dynamic), and the response to a given
glucoseconcentration(static)werecalcu-
lated using the oral C-peptide secretion
model as described previously (14). Dis-
position indexes were calculated by mul-
tiplying indexes of insulin secretion times
indexes of insulin action to determine
whether insulin secretion was appropri-
ate for the degree of insulin resistance.
Statistics
AllresultsareexpressedasmeansSEM.
Student’s two-tailed unpaired t tests
were performed to compare normally
distributed glucose turnover data, and
nonparametric Mann-Whitney tests
were performed to compare the in-
dexes. P  0.05 was considered statis-
tically signiﬁcant.
RESULTS
Plasma glucose, insulin, C-peptide,
and glucagon concentrations
Plasma glucose concentrations were
higher (P  0.001) in diabetic than in
nondiabetic individuals before the meal
(9.1  0.7 vs. 5.2  0.1 mmol/l) and
increased to a higher peak (P  0.001)
after the meal (18.1  0.9 vs. 10.8  0.7
mmol/l), resulting in a greater (P 
0.0001) postprandial integrated response
above basal in diabetic than in nondia-
betic subjects (1,671  125 vs. 557  92
mmol/l over 6 h) (Fig. 1).
Fasting insulin concentrations (59 
9 vs. 37  6 pmol/l) did not differ be-
tween diabetic and nondiabetic individu-
als. However, peak postprandial plasma
insulinconcentrationswerelower(382
54 vs. 673  126 pmol/l; P  0.02) and
occurred later (156  16 vs. 62  7 min;
P  0.001) in diabetic than in nondia-
betic subjects. This led to a smaller (P 
0.001) increase in insulin above basal
(21  4 vs. 52  8 nmol/l over 2 h) in
diabetic subjects during the ﬁrst 2 h after
the meal but no difference in the inte-
grated insulin response above basal for
the entire6ho ft h estudy (79  14 vs.
80  13 nmol/l over 6 h).
C-peptide concentrations did not dif-
fer between diabetic and nondiabetic in-
dividuals before the meal (0.7  0.1 vs.
0.5  0.1 nmol/l). Peak postprandial C-
peptide concentrations (2.8  0.3 vs.
3.9  0.5 nmol/l; P  0.07) tended to be
lower and occur later (191  13 vs. 81 
10 min; P  0.001) in diabetic than in
nondiabetic subjects. As for insulin, the
C-peptide response above basal was
lower(P0.001)indiabeticthaninnon-
diabeticsubjectsfortheﬁrst2haftermeal
ingestion (113  14 vs. 305  35 nmol/l
over 2 h) but did not differ over the entire
6 h of the study (527  76 vs. 637  83
nmol/l over 6 h).
Plasma glucagon concentrations did
not differ in the two groups before meal
ingestion but increased more (P  0.05)
in diabetic than in nondiabetic subjects
during the ﬁrst 2 h after meal ingestion
(5.1  0.9 vs. 2.1  1.0 ng   ml
1   2
h
1). Glucagon concentrations did not
differ in the two groups from 2 h onward,
Basu and Associates
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sponse over the6ho ft h estudy (13.2 
1.8 vs. 11.3  2.1 ng/ml over 6 h).
Indexes of insulin action
Si (4.6  0.8 vs. 10.4  2.9  10
4
min
1   U
1   ml
1) and Sg (0.019 




2A). Likewise, Si* (1.25  0.25 vs.
4.78  1.53  10
4 min
1 per U/ml)
and Sg* (0.0016  0.0006 vs. 0.172 
0.001 min
1) were lower (P  0.02) in
diabetic than in nondiabetic subjects
(data not shown).
Indexes of insulin secretion
total was lower (P  0.01) in diabetic
than in nondiabetic subjects (20.7  3.0
vs. 52.6  4.1  10
9/min) (Fig. 2B).
This result was due to a decrease (P 
0.0001) in dynamic (269.5  44.0 vs.
638.1  69.1  10
9) and a decrease
(P  0.001) in static (19.3  2.9 vs.
46.6  3.8 10
9 min
1).
Disposition indexes, calculated to ad-
just insulin secretion for the prevailing
levelofinsulinaction,allwerelower(P
0.002) in diabetic than in nondiabetic
subjects including DItotal (227  51 vs.
1,104  276  10
14 dl   kg
1   min
1  
pmol
1   l
1), DIdynamic (2,897  748 vs.
11,403.4  1,700  10
14   kg
1  
min
1   pmol
1   l






1   l
1).
Tracer-to-tracee ratios




creased during the ﬁrst 10 min after the
start of the meal in both groups and then
changed minimally thereafter (Fig. 3A).
The plasma ratio of [6,6-
2H2]glucose to
plasma endogenous glucose concentra-
tion (used to calculate EGP) decreased
slightlybutequallyinbothgroupsduring
the ﬁrst hour after meal ingestion. With
the exception of a marked increase that
occurred in one nondiabetic subject, this
ratio then gradually rose from 60 min on-
ward in both groups.
MRa, EGP, and Rd
MRa increased rapidly, reaching a peak in
bothgroupsbetween20and30minpost-
prandially and then returned toward
baseline over the next 6 h (Fig. 3B). Al-
though peak MRa (74.9  5.4 vs. 93.6 
7.0 mol   kg
1   min
1) was slightly
lower (P  0.05) in diabetic than in non-
diabetic subjects, MRa during the ﬁrst 2 h
(6.7  0.5 vs. 7.3  0.5 mmol/kg over
2 h) or over the6ho ft h estudy (12.8 
0.7 vs. 13.4  0.8 mmol/kg over 6 h) did
not differ between groups. Hence,
splanchnic extraction of ingested glucose
also did not differ between the diabetic
and nondiabetic subjects (8.8  0.4 vs.
8.2  0.5 mmol/kg over 6 h).
EGP did not differ in diabetic and
nondiabetic subjects before meal inges-
tion (19.4  0.9 vs. 18.8  0.7 mol  
kg
1   min
1) and decreased in both
groups after meal ingestion. This result
produced no difference in suppression
below basal over the entire 6 h of the
study (4.0  0.3 vs. 3.6  0.2
mmol/kg over 6 h) but a lower (P 
0.05) percent suppression from base-
line in diabetic than in nondiabetic sub-
jects during the ﬁrst 3 h (45.9  1.8 vs.
53.0  3.8%).
Rd did not differ in diabetic and non-




1). Although the increment above
basal did not differ in diabetic and nondi-
abetic individuals over the entire 6 h of
study (8.7  0.7 vs. 9.9  0.7 mmol/kg
over 6 h), it was lower (P  0.01) in dia-
betic subjects during the ﬁrst 3 h after
Figure1—Glucose,insulin,C-peptide,andglucagonconcentrationsobservedindiabetic(f)andnondiabetic( )subjectsbeforeandafteringestion
of a mixed meal at time 0.
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mmol/kg over 3 h).
CONCLUSIONS — The present data
indicatethatalowRdistheprimarycause
of the excessive postprandial rise in glu-
cose concentration in diabetes. Defects in
insulin secretion, insulin action, and glu-
cose effectiveness probably contribute to
thelowratesofpostprandialRd.Although
postprandial suppression of EGP is mod-
estly delayed and is not appropriate for
the prevailing glucose concentration, the
absolute rate of postprandial EGP was
only minimally greater in diabetic than in
nondiabetic subjects. Therefore, whereas
lack of appropriate suppression of EGP
may have exacerbated the postprandial
riseinglucose,itdidnotcauseit.MRadid
not differ between groups.
Despite a greater glycemic excursion,
MRa was slightly lower in diabetic than in
nondiabetic subjects during the ﬁrst hour
after meal ingestion. Therefore, increased
meal appearance was not the cause of ex-
cessive postprandial hyperglycemia. This
ﬁnding is consistent with results from
most, but not all, of the previous experi-
ments that have measured meal appear-
ance using the dual-tracer method (5–
10).Becausetheratioofingestedtracerto
infused tracer markedly increases as in-
gested glucose enters the circulation, the
resultant rapid change in the tracer-to-
tracee ratio introduces error into the cal-
culation of MRa (12,18). This error does
not occur when the plasma ratio of the
ingested and infused tracers is kept con-
stant as was done in the present experi-
ments because measurement of meal
appearancebecomesessentiallymodelin-
dependent (13,14). When the rate of in-
travenously infused tracer is kept
constant, the plasma ratio of the ingested
to infused tracer is determined solely by
the rate of appearance of ingested tracer
because both the tracer and tracee are
cleared in parallel. However, it is note-
worthy that because hyperglycemia is a
potentstimulusofhepaticglucoseuptake
(19), the fact that MRa was comparable in
Figure2—A:Indexesofnetinsulinaction(Si)andnetglucoseeffectiveness(Sg)observedindiabetic(f)andnondiabetic( )subjectsafteringestion
ofamixedmeal.*P0.05versusnondiabetic.B:Indexesofinsulinsecretion(total,dynamic,andstatic)anddispositionindexes(DItotal,DI dynamic,
and DIstatic) observed in diabetic (f) and nondiabetic ( ) subjects after ingestion of a mixed meal. *P  0.05 versus nondiabetic.
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far higher glucose concentrations in the
former is consistent with impaired he-
patic glucose uptake (19,20).
The rate of suppression of EGP after
meal ingestion was slightly slower in dia-
betic than in nondiabetic subjects. This is
similar to the report by Singhal et al. (21)
when postprandial suppression of EGP
was measured using a variable intrave-
nous glucose tracer infusion analogous to
that used in the present experiments. De-
layed suppression of EGP also has been
reported in studies using the dual-tracer
approach (5,6). EGP measured with this
approachiscalculatedbysubtractingMRa
from Ra. Because Ra also is measured with
the constant intravenous tracer, non–
steady-state error caused by the rapid fall
of the plasma tracer-to-tracee ratio that
occurs immediately after eating results in
anunderestimationofRa.Thisisfollowed
by a rise in the tracer-to-tracee ratio that
results in an overestimation of Ra. There-
fore, although the absolute rates may be
wrong, if the sizes of the errors in both
MRa and Ra are the same in both groups,
then conclusions regarding the temporal
pattern of suppression of EGP of one
group relative to the other could be cor-
rect. This explanation possibly accounts
forthefactthattheconclusioninprevious
studies using the dual-tracer method (5–
10) and the present studies as well as
those of Singhal et al. (21) was that post-
prandial suppression of EGP is delayed in
diabetes.
EGP did not differ in diabetic and
nondiabetic subjects before meal inges-
tion. However, plasma glucose concen-
trations were substantially higher in
diabetic than in nondiabetic subjects. Be-
cause hyperglycemia suppresses EGP,
rates were not appropriate for the prevail-
ing glucose concentration (22). We and
others (2,3,23,24) have reported that the
absolute rate of EGP is increased in indi-
viduals with severe diabetes as indicated
by marked fasting hyperglycemia. In ad-
dition, diabetic subjects in the present
study had an A1C of 6.8% at the time of
screening, indicating excellent glycemic
control. Therefore, it is probable that ab-
normalitiesinregulationofEGPwouldbe
even more marked in individuals with
poor glycemic control. Therefore, exces-
sivehepaticglucosereleaseprobablycon-
tributes to postprandial hyperglycemia in
individuals with substantially elevated
preprandial glucose concentrations. De-
layedinsulinsecretion,insulinresistance,
and an increase in glucagon concentra-
Figure 3—A: Pattern of change in the plasma [6-
3H]glucose-to-[1-
13C]glucose ratio (used to
calculate the rate of meal appearance) (right panel) and the [6,6-
2H2]glucose–to–endogenous
glucose ratio (used to calculate endogenous glucose production) (left panel) observed in diabetic
(f) and nondiabetic ( ) subjects before and after ingestion of a mixed meal at time 0. B: Pattern
of change of the rate of appearance of meal glucose (top panel), endogenous glucose production
(middlepanel),andtherateofglucosedisappearance(lowerpanel)observedindiabetic(f)and
nondiabetic ( ) subjects before and after ingestion of a mixed meal at time 0.
Prandial glucose turnover in type 2 diabetes
870 DIABETES CARE, VOLUME 32, NUMBER 5, MAY 2009tions all could have contributed to im-
paired postprandial suppression of EGP.
Furthermore, EGP was lower in diabetic
than in nondiabetic subjects during 3 to
6 h postprandially probably because of
higherinsulinandglucoseconcentrations
and slightly lower glucagon concentra-
tions in diabetic subjects. The present ex-
perimental design cannot distinguish
between these possibilities.
Rd was substantially lower in diabetic
subjects during the ﬁrst several hours af-
ter meal ingestion when the excessive rise
in glucose occurred. Because splanchnic
glucoseclearanceandtherefore,byimpli-
cation, hepatic glucose uptake, did not
differ between groups, decreased Rd was
the primary cause of hyperglycemia in di-
abetic subjects. The overall pattern of
postprandialglucosemetabolism,namely
amarkeddecreaseinRdimmediatelyafter
meal ingestion when glucose concentra-
tions are rising in the presence of normal
MRaandminimalchangesinpostprandial
suppression of EGP, strongly resembles
that which we have recently reported in
individuals with impaired fasting glucose
(25). The pattern differs from that in pre-
viousstudies(5–10)usingthedual-tracer
approach, in which postprandial Rd has
been reported to be unchanged or in-
creased relative to that in nondiabetic
subjects. In retrospect, these discrepan-
cies are readily explainable because Rd is
calculated by subtracting the change in
glucosemassfromRa.Therefore,errorsin
calculation of Ra result in errors in calcu-
lation of Rd.
Multiplefactorsprobablycontributed
to lower postprandial Rd. The difference
in Rd between diabetic and nondiabetic
subjects closely paralleled the difference
in the pattern in insulin concentrations
withbothbeinglowerindiabeticsubjects
during the initial several hours after meal
ingestion followed by concentrations that
were higher than those observed in non-
diabetic subjects from 3 h onward. In ad-
dition, postprandial insulin action and
glucose effectiveness were impaired in di-
abetic subjects. These abnormalities all
probablycontributedtothelowerRddur-
ing the initial 2 h after meal ingestion.
Factors that contribute to postprandial
glucose turnover include meal content,
meal size, duration, and severity of diabe-
tes among others. Our experimental de-
sign is unable to determine the impact of
these factors. Furthermore, although dis-
position indexes were lower in diabetic
subjects, their interpretation needs to be
considered in the context of a mixed meal
(14).
Although the total 6-h postprandial
insulin concentrations were similar be-
tween groups, the insulin secretory re-
sponse in the diabetic subjects was
sluggish for the ﬁrst 2 h probably because
of reduced sensitivity of the -cells to the
glucose challenge. Furthermore, our ob-
servations are relevant only for those sub-
jects whose type 2 diabetes is relatively
earlyinitsnaturalhistoryandiswellcon-
trolled with oral antidiabetic agents and
therefore cannot be extrapolated to those
withgrosslyimpaired-cellreservesafter
a longer duration of the disease.
In summary, when measured using
methods that avoid non–steady-state er-
ror, MRa of ingested glucose was normal
and suppression of EGP was only slightly
impaired. However, when considered in
thelightoftheprevailingglucoseconcen-
tration,bothareabnormal.Incontrast,Rd
was lower in diabetic subjects for several
hours after meal ingestion owing to a
combination of defects in insulin secre-
tion, insulin action, and glucose effective-
ness. Therefore, agents that correct only
one of these abnormalities are unlikely to
fully restore postprandial metabolism to
normal in type 2 diabetes.
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